BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17369193)

  • 1. The role of BLyS/BLyS receptors in anti-chromatin B cell regulation.
    Hondowicz BD; Alexander ST; Quinn WJ; Pagán AJ; Metzgar MH; Cancro MP; Erikson J
    Int Immunol; 2007 Apr; 19(4):465-75. PubMed ID: 17369193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of systemic lupus erythematosus in NZM 2328 mice in the absence of any single BAFF receptor.
    Jacob CO; Yu N; Guo S; Jacob N; Quinn WJ; Sindhava V; Cancro MP; Goilav B; Putterman C; Migone TS; Stohl W
    Arthritis Rheum; 2013 Apr; 65(4):1043-54. PubMed ID: 23334904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rGel/BLyS fusion toxin specifically targets malignant B cells expressing the BLyS receptors BAFF-R, TACI, and BCMA.
    Lyu MA; Cheung LH; Hittelman WN; Marks JW; Aguiar RC; Rosenblum MG
    Mol Cancer Ther; 2007 Feb; 6(2):460-70. PubMed ID: 17267661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel receptor for B lymphocyte stimulator that is mutated in a mouse strain with severe B cell deficiency.
    Yan M; Brady JR; Chan B; Lee WP; Hsu B; Harless S; Cancro M; Grewal IS; Dixit VM
    Curr Biol; 2001 Oct; 11(19):1547-52. PubMed ID: 11591325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of BLyS on the activity of peripheral B lymphocytes mediated by BLyS receptors in patients with systemic lupus erythematosus.
    Cheng Y; Yan S; Zhao W; Huang Q; Lian L; Wei W
    Scand J Clin Lab Invest; 2013 Mar; 73(2):141-7. PubMed ID: 23336587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transmembrane activator, calcium modulator, and cyclophilin ligand interactor drives plasma cell differentiation in LPS-activated B cells.
    Ozcan E; Garibyan L; Lee JJ; Bram RJ; Lam KP; Geha RS
    J Allergy Clin Immunol; 2009 Jun; 123(6):1277-86.e5. PubMed ID: 19427685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B lymphocyte stimulator modulates number and function of endothelial progenitor cells in systemic lupus erythematosus.
    Spinelli FR; Barbati C; Cecarelli F; Morello F; Colasanti T; Vomero M; Massaro L; Orefice V; Alessandri C; Valesini G; Conti F
    Arthritis Res Ther; 2019 Nov; 21(1):245. PubMed ID: 31752963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation and characterization of LymphoStat-B, a human monoclonal antibody that antagonizes the bioactivities of B lymphocyte stimulator.
    Baker KP; Edwards BM; Main SH; Choi GH; Wager RE; Halpern WG; Lappin PB; Riccobene T; Abramian D; Sekut L; Sturm B; Poortman C; Minter RR; Dobson CL; Williams E; Carmen S; Smith R; Roschke V; Hilbert DM; Vaughan TJ; Albert VR
    Arthritis Rheum; 2003 Nov; 48(11):3253-65. PubMed ID: 14613291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and effects of B-lymphocyte stimulator and its receptors in T cell-mediated autoimmune arthritis.
    Chang Y; Sun X; Jia X; Xu S; Wei F; Yang X; Wei W
    Int Immunopharmacol; 2015 Feb; 24(2):451-457. PubMed ID: 25598291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local BLyS production by T follicular cells mediates retention of high affinity B cells during affinity maturation.
    Goenka R; Matthews AH; Zhang B; O'Neill PJ; Scholz JL; Migone TS; Leonard WJ; Stohl W; Hershberg U; Cancro MP
    J Exp Med; 2014 Jan; 211(1):45-56. PubMed ID: 24367004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BLyS receptor signatures resolve homeostatically independent compartments among naïve and antigen-experienced B cells.
    Treml LS; Crowley JE; Cancro MP
    Semin Immunol; 2006 Oct; 18(5):297-304. PubMed ID: 16919470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLR stimulation modifies BLyS receptor expression in follicular and marginal zone B cells.
    Treml LS; Carlesso G; Hoek KL; Stadanlick JE; Kambayashi T; Bram RJ; Cancro MP; Khan WN
    J Immunol; 2007 Jun; 178(12):7531-9. PubMed ID: 17548587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation and accumulation of B cells in TACI-deficient mice.
    Yan M; Wang H; Chan B; Roose-Girma M; Erickson S; Baker T; Tumas D; Grewal IS; Dixit VM
    Nat Immunol; 2001 Jul; 2(7):638-43. PubMed ID: 11429549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TACI-dependent APRIL signaling maintains autoreactive B cells in a mouse model of systemic lupus erythematosus.
    Tran NL; Schneider P; Santiago-Raber ML
    Eur J Immunol; 2017 Apr; 47(4):713-723. PubMed ID: 28267197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
    Abu-Rish EY; Amrani Y; Browning MJ
    Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. impaired B cell maturation in mice lacking BLyS.
    Gross JA; Dillon SR; Mudri S; Johnston J; Littau A; Roque R; Rixon M; Schou O; Foley KP; Haugen H; McMillen S; Waggie K; Schreckhise RW; Shoemaker K; Vu T; Moore M; Grossman A; Clegg CH
    Immunity; 2001 Aug; 15(2):289-302. PubMed ID: 11520463
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Signaling by the tumor necrosis factor receptor superfamily in B-cell biology and disease.
    Rickert RC; Jellusova J; Miletic AV
    Immunol Rev; 2011 Nov; 244(1):115-33. PubMed ID: 22017435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors.
    Zhang X; Park CS; Yoon SO; Li L; Hsu YM; Ambrose C; Choi YS
    Int Immunol; 2005 Jun; 17(6):779-88. PubMed ID: 15908449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TACI-Ig induces immune balance of Th cells in MLN via BLyS/APRIL-receptors signaling in rats with adjuvant-induced arthritis.
    Qin Q; Chang Y; Wang D; Wu Y; Zhang LL; Wei W
    Int Immunopharmacol; 2011 Dec; 11(12):2167-75. PubMed ID: 21996540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease.
    Gross JA; Johnston J; Mudri S; Enselman R; Dillon SR; Madden K; Xu W; Parrish-Novak J; Foster D; Lofton-Day C; Moore M; Littau A; Grossman A; Haugen H; Foley K; Blumberg H; Harrison K; Kindsvogel W; Clegg CH
    Nature; 2000 Apr; 404(6781):995-9. PubMed ID: 10801128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.